Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Global News: EU Delays Launch of Eudamed Database
...
Register
PAMA Report: ACLA Tries for Decisive Blow in Federal Court Case
...
Register
ACLA Goes for Knockout Punch in PAMA Lawsuit
...
Register
Kellison and G2 Intelligence Honor Dr. Sidney Goldblatt
...
Register
Medicare Reimbursement: CMS Eases Coverage Restrictions on NGS Testing of Early-Stage Cancer Patients
...
Register
Lab Fails in Bid to Get Medicare Payment Suspension Set Aside
...
Register
Mergers, Acquisitions & Asset Sales Analysis – October 2019
...
Register
Diagnostic Deals: A roundup of the key mergers, acquisitions, alliances, licenses and other strategic transactions from the past month
Although briskness in alliances partially offset sluggishness in M&A, October was far less dynamic than September for strategic deal making within the diagnostics sector. Here’s an overview of the key deals that did come down over the 4-week period beginning in late September 2019.
Strategic Alliances, Partnerships & Collaborations Analysis – October 2019
...
Register
FDA Watch: New Process for Simultaneous Review IVD Tests Used in Cancer Drug Trials
Typically, in vitro diagnostic (IVDs) tests used in investigational cancer drug trials require two submissions: one for the IVD test and another for the drug. But on Oct. 9, the FDA issued final guidance allowing companies to submit for simultaneous review for the clinical trial.